Dana ChrengAssociate Director- Drug Substance Manufacturing Group at Ionis Pharmaceuticals
Agenda Sessions
Utilization of a TFF skid for solution-phase deprotection and small molecule removal in oligonucleotide manufacturing
9:20amView SessionYMC Panel Session
10:00amView Session